Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01256229 · ClinicalTrials.gov registry record · Phase 1
Outcomes In Children With Developmental Delay And Deafness
A Phase 1 study of Hearing Loss and Deafness, sponsored by Stanford University.
- Completed
- Registry status
- Phase 1
- Development phase
- 303
- Enrollment target
- 2
- Study locations
NCT01256229: Completed Phase 1 study of Hearing Loss and Deafness, sponsored by Stanford University.
NCT01256229 is a Phase 1 study of Hearing Loss and Deafness that has completed, run by Stanford University. The registered enrollment target is 303 participants, below the 6,116-participant average among 58 other Hearing Loss trials with a reported enrollment target (95% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01256229, a Phase 1 study of Hearing Loss and Deafness, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 303 participants
- Enrollment target
- 2
- Study locations
Study Summary
Children with special needs require complex, individualized therapy to maximize their long-term quality of life. One subset of children with special needs includes those with both developmental delays and deafness. Currently, there is little compelling evidence supporting the idea that cochlear implantation provides benefit to children that don't have the cognitive potential to develop normal speech and language. We will perform a prospective, randomized clinical trial to answer the question of which intervention provides more benefit to this population of children using validated, norm-referenced tests. Our long-term goal is to develop guidelines that may help when selecting a treatment for hearing loss in a child with developmental delays. This proposal is significant because children with special needs are deserving of evidence upon which to base treatment decision-making, but remain under-represented in the medical literature and are often not studied. This research is designed to meet the criteria for the National Institutes of Health road map because it will generate this type of objective evidence that can directly improve patient care.
Conditions Studied
Interventions
- DEVICE hearing aids
- DEVICE cochlear implantation
Study Locations (2)
California
- Stanford University School of Medicine - Stanford
Texas
- Baylor College of Medicine - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 303 participants |
| Start Date | 2009-09 |
| Est. Completion | 2016-09 |
| Phase | Phase 1 |
What the finished NCT01256229 record still lists
NCT01256229 is an interventional study that assigns participants to a tested intervention. The registered 303 participants enrollment target is mid-sized for trials with a published cap, below the 6,116-participant average among 58 other Hearing Loss trials with a reported enrollment target (95% lower).
The record links to 2 conditions, with Hearing Loss appearing as the primary indexed condition, and to 2 interventions - of which hearing aids is the first listed.
NCT01256229 reports a single indexed study location in California, Texas.
Frequently Asked Questions
What is clinical trial NCT01256229 about?
NCT01256229 is a clinical study titled "Outcomes In Children With Developmental Delay And Deafness". Children with special needs require complex, individualized therapy to maximize their long-term quality of life. One subset of children with special needs includes those with both developmental delays and deafness. Currently, there is little compelling evidence supporting the idea that cochlear impl...
What is the current status of trial NCT01256229?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 303 participants. The study started on 2009-09. Estimated completion is 2016-09.
What conditions does trial NCT01256229 study?
This clinical trial studies the following conditions: Hearing Loss, Deafness.
What interventions are being tested in trial NCT01256229?
The interventions under investigation include: hearing aids (DEVICE), cochlear implantation (DEVICE).
Who is sponsoring clinical trial NCT01256229?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01256229 being conducted?
This trial has 2 study locations across California, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hearing Loss
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01256229's enrollment target sits among peer trials
303 19th of 58 higher than 40 of 58 other Hearing Loss trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hearing Loss trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Testing the Addition of Pedmark to Cisplatin Chemotherapy for Reducing Drug-Induced Ear Damage in Men With Stage II-III Metastatic Testicular Germ Cell Tumors
RECRUITING · Phase 1
-
Improving Access and Affordability of Adult Hearing Healthcare
RECRUITING · NA
-
AI Noise Reduction in Phonak Hearing Aids
RECRUITING · NA
-
Investigation of a Device to Deliver Intra-Operative Therapeutic Hypothermia for Hearing Preservation in Cochlear Implantation
RECRUITING · NA
-
Auditory-Cognitive Training to Optimize Outcomes for Older CI Users
RECRUITING · NA
-
NIDCD Otolaryngology Clinical Protocol Biospecimen Bank
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05508971 · 303 participants · NA
Treatment of Obstructive Sleep Apnea With Personalized Surgery in Children With Down Syndrome (TOPS-DS)
- NCT04750616 · 304 participants · Phase 2
NAD+ Augmentation in Cardiac Surgery Associated Myocardial Injury Trial
- NCT04994717 · 304 participants · Phase 3
Study Comparing Blinatumomab Alternating With Low-intensity Chemotherapy Versus Standard of Care Chemotherapy for Older Adults With Newly Diagnosed Philadelphia-negative B-cell Precursor Acute Lymphoblastic Leukemia
- NCT06036147 · 304 participants · NA
Concussion Health Improvement Program
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia